Wikipedia -WSS

Wikipedia

author：fashion 2025-09-30 22:41:42 - browse：9977

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Heart disease and mental health: A look at cardiac psychology

Wikipedia

WSS

Heart disease and mental health: A look at cardiac psychology

The SUPPORT Act is critical to fighting the opioid crisis

Generative AI mines health records to identify patients’ social needs

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

There’s a way to spot data fakery. All journals should be using it

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Duchenne breakthrough therapy leaves behind pioneering families

Health and fitness trackers are measuring the wrong things

Apple is now the first public company to be valued at $3 trillion

New menopause drug shows promise in relief for hot flashes

What does generative AI mean for health care? We asked experts

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Health and fitness trackers are measuring the wrong things

New air purifier tech could be key to improving indoor air quality

US jobless claims fall again as labor market continues to flash strength

hotspot

When a patient nears the end, a feared therapy can comfort

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Health and fitness trackers are measuring the wrong things

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

'CMA Fest' 2023: How to watch, who is performing and more

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

entertainment

Wikipedia

explore

focus